🇺🇸 FDA
Pipeline program

KXV01 TCR Lentinvivo Injection

KXV01-R101

Phase 1 small_molecule active

Quick answer

KXV01 TCR Lentinvivo Injection for Advanced Solid Cancer is a Phase 1 program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).

Program details

Company
The First People's Hospital of Lianyungang
Indication
Advanced Solid Cancer
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials